Consistent with this, various cancer cell lines, including the A549, HCC4006, H2009 (lung cancer cell lines) and MDA-MB231 (breast cancer cell line) cells, showed increased sensitization to TRAIL-induced cell death upon depletion of MLKL (Fig. 1c). This evidence concerns the gene MLKL and breast carcinoma.